ロード中...
Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
BACKGROUND: To evaluate the efficacy and safety of an intravitreal dexamethasone implant (Ozurdex®; Allergan Inc, Irvine, CA, USA) in patients with persistent diabetic macular edema (DME) over a 6-month follow-up period. METHODS: Seventeen patients (20 eyes) affected by DME were selected. The mean a...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3720664/ https://ncbi.nlm.nih.gov/pubmed/23901252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S48364 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|